COVID-related hospitalization, intensive care treatment, and all-cause mortality in patients with psychosis and treated with clozapine.

MLA

Govind, Risha, et al. “COVID-Related Hospitalization, Intensive Care Treatment, and All-Cause Mortality in Patients with Psychosis and Treated with Clozapine.” European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, vol. 56, Mar. 2022, pp. 92–99. EBSCOhost, https://doi.org/10.1016/j.euroneuro.2022.01.007.

APA

Govind, R., de Freitas, D. F., Pritchard, M., Khondoker, M., Teo, J. T., Stewart, R., Hayes, R. D., & MacCabe, J. H. (2022). COVID-related hospitalization, intensive care treatment, and all-cause mortality in patients with psychosis and treated with clozapine. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 56, 92–99. https://doi.org/10.1016/j.euroneuro.2022.01.007

Chicago

Govind, Risha, Daniela Fonseca de Freitas, Megan Pritchard, Mizanur Khondoker, James T Teo, Robert Stewart, Richard D Hayes, and James H MacCabe. 2022. “COVID-Related Hospitalization, Intensive Care Treatment, and All-Cause Mortality in Patients with Psychosis and Treated with Clozapine.” European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology 56 (March): 92–99. doi:10.1016/j.euroneuro.2022.01.007.